- Home
- ALDX vs FFIC Comparison
ALDX vs FFIC Comparison
Compare ALDX & FFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- FFIC
- Stock Information
- Founded
- ALDX 2004
- FFIC 1929
- Country
- ALDX United States
- FFIC United States
- Employees
- ALDX N/A
- FFIC N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- FFIC Major Banks
- Sector
- ALDX Health Care
- FFIC Finance
- Exchange
- ALDX Nasdaq
- FFIC Nasdaq
- Market Cap
- ALDX 342.3M
- FFIC 408.4M
- IPO Year
- ALDX 2014
- FFIC 1995
- Fundamental
- Price
- ALDX $5.09
- FFIC $14.04
- Analyst Decision
- ALDX Strong Buy
- FFIC
- Analyst Count
- ALDX 2
- FFIC 0
- Target Price
- ALDX $9.50
- FFIC N/A
- AVG Volume (30 Days)
- ALDX 776.7K
- FFIC 187.4K
- Earning Date
- ALDX 11-06-2025
- FFIC 10-23-2025
- Dividend Yield
- ALDX N/A
- FFIC 6.29%
- EPS Growth
- ALDX N/A
- FFIC N/A
- EPS
- ALDX N/A
- FFIC N/A
- Revenue
- ALDX N/A
- FFIC $137,137,000.00
- Revenue This Year
- ALDX N/A
- FFIC $113.87
- Revenue Next Year
- ALDX $63.48
- FFIC $5.75
- P/E Ratio
- ALDX N/A
- FFIC N/A
- Revenue Growth
- ALDX N/A
- FFIC N/A
- 52 Week Low
- ALDX $1.14
- FFIC $10.65
- 52 Week High
- ALDX $7.20
- FFIC $18.59
- Technical
- Relative Strength Index (RSI)
- ALDX 37.78
- FFIC 68.10
- Support Level
- ALDX $5.48
- FFIC $13.27
- Resistance Level
- ALDX $5.88
- FFIC $13.83
- Average True Range (ATR)
- ALDX 0.29
- FFIC 0.27
- MACD
- ALDX -0.10
- FFIC 0.02
- Stochastic Oscillator
- ALDX 10.63
- FFIC 86.52
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About FFIC Flushing Financial Corporation
Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.